OKYO Pharma (NASDAQ:OKYO) Trading Up 0.5% – Should You Buy?

OKYO Pharma Limited (NASDAQ:OKYO) shares were up 0.5% during mid-day trading on Monday . The stock traded as high as $1.95 and last traded at $1.85. Approximately 2,459,157 shares changed hands during trading, an increase of 1,766% from the average daily volume of 131,758 shares. The stock had previously closed at $1.84.

Analyst Upgrades and Downgrades

Separately, HC Wainwright restated a “buy” rating and issued a $7.00 price objective on shares of OKYO Pharma in a research note on Monday, May 5th.

OKYO Pharma Stock Performance

The stock has a 50 day moving average price of $1.38 and a two-hundred day moving average price of $1.22.

Hedge Funds Weigh In On OKYO Pharma

An institutional investor recently bought a new position in OKYO Pharma stock. FNY Investment Advisers LLC acquired a new position in shares of OKYO Pharma Limited (NASDAQ:OKYO) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 20,000 shares of the company’s stock, valued at approximately $25,000. FNY Investment Advisers LLC owned 0.06% of OKYO Pharma at the end of the most recent reporting period. 2.97% of the stock is currently owned by institutional investors.

OKYO Pharma Company Profile

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.